Improving to Four or Fewer Monthly Headache Days Per Month Provides a Clinically Meaningful Therapeutic Target for Patients with Chronic Migraine

ConclusionParticipants improving to ≤ 4 MHDs reported less acute medication use and improved patient-reported outcomes, suggesting that 4 MHDs may be a useful patient-centric treatment target when treating CM.Trial registrationClinicalTrials.gov (Identifier: NCT02974153) (https://clinicaltrials.gov/ct2/show/NCT02974153).

http://link.springer.com/10.1007/s40122-023-00525-x

Source: Pain and Therapy - June 28, 2023 Category: Anesthesiology Source Type: research